Welcome to Kintsugi
Kintsugi is the art of repairing fractures in ceramics with gold. What once was broken becomes stronger and more beautiful. We apply this philosophy to mental health, developing technology to fill the gaps in behavioral health infrastructures and scale access to mental health care.
Kintsugi is a clinically validated voice biomarker technology that harnesses the power of AI and voice to detect signs of depression and anxiety. A flexible, end-to-end behavioral health solution, Kintsugi Voice helps payors, providers and healthcare partners conduct mental health screenings accurately and at scale.
Founded in 2019 by two ambitious women, Grace Chang and Rima Seiilova-Olson, shared a common challenge in accessing quality mental healthcare services. They combined their strengths to create voice biomarker technology that has the power to positively impact the lives of billions around the world.
Kintsugi has raised $28M to date, with a $20M Series A led by Insight Partners in 2022 and $8M seed funding led by Acrew Capital and the National Science Foundation in 2019. The Bay Area team has received dozens of accolades and distinctions for their AI technology, most recently named to Fierce 15 2023 and Forbes AI 50 in 2022.
Grace Chang
Grace, an artist and builder at heart, flawed and open-minded, generous and persistent, created this company to help all of us grow and flourish.
Grace Chang
Prentice Tom, MD
Prentice, a pioneer in healthcare, is excited to revolutionize our ability to relieve suffering for two of the most unrecognized and under-treated mental health conditions: depression and anxiety.
Prentice Tom, MD
Deepak Ghosh
Deepak believes that mental health impacts everyone in some way, whether it's personally or through a friend or loved one, and is excited to be part of the work that has the potential to change lives by enabling access to mental wellness at scale.
Deepak Ghosh
Albert Ihochi
Albert believes that mental health is criminally underserved in today’s global society and is excited to scale mental health to those in need, having had firsthand experience with family members who have had to deal with depression and anxiety.
Albert Ihochi
Our partners are seeing the difference
Marketplace Member
Large Payor
Chief Medical Officer
Steven Bibevski, MD
Pediatric Cardiac Surgeon - Joe DiMaggio Children’s Hospital
Kelli Bravo
VP, Healthcare and Life Sciences Strategy and Solutions at Pega
Robin Deterding, MD
Chief Pediatric Pulmonary and Sleep Medicine, University of Colorado - Children's Hospital Colorado
Brand Assets
Please download our brand assets for media use
Proven results
In a recent pilot study with a large partner, Kintsugi Voice successfully identified 40% more patients with some level of depression vs. PHQ-2. Not just in a binary output, but by level of severity. This means you can provide the right level of preventive behavioral healthcare at the right time for each and every patient.
Clinically validated
At Kintsugi, we train and validate our voice biomarker AI models by conducting clinical trials with prestigious academic institutions and collaborating with top experts and research partners in healthcare.
Contact us
Talk to our communications team for more updates